SHINE Technologies is partnering with Sumitomo Corporation of Americas (SCOA), a leading global trading and investment company, the company announced today. According to a release, the partnership, formalized through a…
SHINE Technologies has been selected to provide a 14 mega electron volt deuterium-tritium fusion system to the U.K. Atomic Energy Authority (UKAEA)’s Lithium Breeding Tritium Innovation (LIBRTI) program in 2027,…
SHINE Technologies and WARF Therapeutics today announced pre-clinical research results from collaborative efforts with the Advanced Radiotheranostics Lab at the University of Wisconsin. According to a release, the studies showed…
SHINE Technologies announced recently that it is entering into a supply agreement with GlyTherix Ltd, an Australian targeted-radiotherapy company specializing in developing antibody radiopharmaceuticals for solid tumors. According to a…
SHINE Technologies was awarded $32 million from the Department of Energy’s National Nuclear Security Administration (DOE/NNSA), the organization announced today. According to a release, the funds will aid in the…
SHINE Technologies announced recently that it has partnered with Blue Earth Therapeutics, a company focused on developing innovative radiopharmaceuticals. According to a release, SHINE has provided to Blue Earth Therapeutics…
SHINE Technologies has signed a Memorandum of Understanding (MOU) with Orano to cooperate in the development of the U.S. pilot plant with commercial-scale technology for recycling used nuclear fuel from…
SHINE Technologies has raised $70 million in additional funding to accelerate the commercialization of near-term applications of fusion technology, the company announced today. The round was led by existing investors…
SHINE Technologies has demonstrated clearly visible Cherenkov radiation produced by fusion for what is believed to be the first time in history, the company announced today. “Fusion has long captured…
SHINE Technologies announced today it is opening the largest facility in North America dedicated to producing a medical isotope used in targeted cancer therapies. According to a release, the facility,…
